ALCAM and osteosarcoma: CD166.BBζ-CAR T cells showed increased cytotoxicity to CD166/ALCAM-positive human osteosarcoma cells, but not to CD166/ALCAM-negative cells compared to non-transduced T cells, showing a correlation between CD166/ALCAM expression and cytotoxicity, and thus, specificity [59].